Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-02T20:06:31.420Z Has data issue: false hasContentIssue false

Supplementation of thyroid hormone in children undergoing cardiac surgery

Published online by Cambridge University Press:  15 August 2006

Richard D. Mainwaring
Affiliation:
University of Tennessee, Memphis, Department of Surgery, Memphis, Tennessee, USA
Jerald C. Nelson
Affiliation:
Quest Diagnostics Nichols Institute, San Juan Capistrano, California, USA

Abstract

Triiodothyronine has been introduced as a promising new supplement for patients undergoing openheart surgery. This manuscript will review the existing literature regarding supplementation with triiodothyronine in children.

Infants and children undergoing cardiac surgery experience a profound decrease in levels of free and total triiodothyronine. These decreases are of sufficient magnitude to effect cardiac function. Supplementation with triiodothyronine has been shown to enhance myocardial performance, improve recovery of circulating levels of triiodothyronine, and to result in an increase in mixed venous oxygen saturation. As encouraging as these results are, there is no definitive study which demonstrates that triiodothyronine improves clinical outcome in children. Thus, while triiodothyronine appears to have promise as a supplement for children undergoing openheart surgery, more studies are needed to establish the efficacy of such therapy scientifically.

Type
Review
Copyright
2002 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)